biomarkers

Open Access
Stratifying Skin Cancer Patients and Guiding Treatment Decisions Through Combined p53 and p63 Expression Analysis
GEORGIA VAIRAKTARI, EFSTATHIA VAIRAKTARI, ALEXANDER SCHRAMM, SPYRIDOULA DERKA, VERONIKA PAPAKOSTA, SPYRIDON STAVRIANOS, AIKATERINI BINI, ANDREAS SAKKAS, MARIA KOURI, ANTONIS VYLLIOTIS, ANDREAS LAZARIS and MARCEL EBELING

In Vivo September 2025, 39 (5) 2599-2608; DOI: https://doi.org/10.21873/invivo.14060
Open Access
Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma
ERGİN AYDEMİR, FUNDA YILMAZ, ALPER TÜRKEL, ÖZTÜRK ATEŞ and MUTLU DOĞAN

In Vivo September 2025, 39 (5) 2976-2985; DOI: https://doi.org/10.21873/invivo.14098
Open Access
Bone Metabolism-related Serum Biomarkers and Nutritional Markers for Bone Fractures in Living-donor Kidney Transplant Recipients
SHUNTA HORI, MITSURU TOMIZAWA, KUNIAKI INOUE, TATSUO YONEDA, KENTA ONISHI, YOSUKE MORIZAWA, DAISUKE GOTOH, YASUSHI NAKAI, MAKITO MIYAKE, KAZUMASA TORIMOTO, NOBUMICHI TANAKA and KIYOHIDE FUJIMOTO

In Vivo May 2025, 39 (3) 1492-1504; DOI: https://doi.org/10.21873/invivo.13949
Open Access
Prognostic Value of Tumor Tissue Up-regulated microRNAs in Clear Cell Renal Cell Carcinoma (ccRCC)
MARTIN PESTA, IVAN TRAVNICEK, VLASTIMIL KULDA, PAVEL OSTASOV, JINDRA WINDRICHOVA, KATERINA HOUFKOVA, TEREZA KNIZKOVA, BARBORA BENDOVA, ONDREJ HES, MILAN HORA, ONDREJ TOPOLCAN and JIRI POLIVKA

In Vivo July 2024, 38 (4) 1799-1805; DOI: https://doi.org/10.21873/invivo.13631
Open Access
ARID1 and BRG1 Expression in Endometrial Cancer
EMMANUEL N. KONTOMANOLIS, PANAGIOTIS SYMEONIDIS, KONSTANTINOS NIKOLETTOS, PARASKEVAS PERROS, ACHIM RODY, PANAGIOTIS TSIKOURAS, NIKOLAOS NIKOLETTOS and ALEXANDRA GIATROMANOLAKI

In Vivo May 2024, 38 (3) 1260-1265; DOI: https://doi.org/10.21873/invivo.13563
Open Access
Proteomics in Psoriasis: Recent Advances
GEORGIOS LEOTSAKOS, IOANNIS KATAFIGIOTIS, IOANNIS LEOTSAKOS, FIORI KOUSTA, ARISTEIDIS MOLYMPAKIS, AIKATERINI PERIMENI and MICHAEL KOUTSILIERIS

In Vivo May 2024, 38 (3) 1000-1008; DOI: https://doi.org/10.21873/invivo.13533
Open Access
Admission Emergency Department Point-of-care Biomarkers for Prediction of Early Mortality in Spontaneous Intracerebral Hemorrhage
EUGENIA-MARIA MURESAN, ADELA GOLEA, STEFAN CRISTIAN VESA, IULIA GIVAN and LACRAMIOARA PERJU-DUMBRAVA

In Vivo May 2022, 36 (3) 1534-1543; DOI: https://doi.org/10.21873/invivo.12864
You have access
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma
MAKI YOSHINO, HIROKI ISHIHARA, YUDAI ISHIYAMA, HIDEKAZU TACHIBANA, DAISUKE TOKI, KAORI YAMASHITA, HIROHITO KOBAYASHI, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, TOSHIO TAKAGI, JUNPEI IIZUKA, HIDEKI ISHIDA, TSUNENORI KONDO and KAZUNARI TANABE

In Vivo September 2021, 35 (5) 2855-2862; DOI: https://doi.org/10.21873/invivo.12573
You have access
Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma – Mini-Review
MARIAN LIBERKO, KATARINA KOLOSTOVA, ARPAD SZABO, ROBERT GURLICH, MARTIN OLIVERIUS and RENATA SOUMAROVA

In Vivo January 2021, 35 (1) 31-39; DOI: https://doi.org/10.21873/invivo.12229
You have access
Prognostic Factors After Surgical Treatment of Liver Metastases from Breast Cancer – 19 Years of Experience
KRISTÝNA PROCHÁZKOVÁ, KRISTÝNA PIVOVARČÍKOVÁ, MILENA ROUŠAROVÁ, JOSEF VODIČKA, PETR HOŠEK, INKA TŘEŠKOVÁ, ONDŘEJ HES, RADEK KUČERA, ONDŘEJ TOPOLČAN and VLADISLAV TŘEŠKA

In Vivo January 2021, 35 (1) 417-422; DOI: https://doi.org/10.21873/invivo.12273

Main menu

User menu

Search

biomarkers

Pages